Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0EBLME
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TCO-trastuzumab trast-v1a-XL11
|
|||||
| Synonyms |
TCO-trastuzumab trast-v1a-XL11
Click to Show/Hide
|
|||||
| Organization |
SYNAFFIX B.V.
|
|||||
| Drug Status |
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
trastuzumab trast-v1a
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
DBCO-Azide Click Chemistry Conjugation
|
|||||
| Combination Type |
Bis-BCN-TCO-XL11
|
|||||